Andrew Taylor Lawrence, the Chief Monetary Officer of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), lately acquired 1,000 shares of the corporate’s widespread inventory. The acquisition, made on December 19, was executed at a weighted common worth of $4.83 per share, totaling roughly $4,830. The transaction comes because the inventory trades close to its 52-week low of $4.22, having declined about 9% previously week. This transaction will increase Lawrence’s whole holdings to 344,960 shares. The shares had been acquired in a number of transactions, with costs starting from $4.81 to $4.89. In line with InvestingPro information, the corporate maintains spectacular gross revenue margins of 93% and holds additional cash than debt on its steadiness sheet. For deeper insights into insider buying and selling patterns and extra monetary metrics, InvestingPro provides 8 extra key recommendations on OBIO’s monetary well being and market place.
This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.